Velibey Yalçın, Parsova Emre Can, Ceylan Ufuk Sadık, Güzelburc Özge, Demir Koray, Yıldız Ufuk, Şafak Aylin, Akdeniz Evliya, Güvenç Tolga Sinan, Bozbeyoğlu Emrah, Tekkeşin Ahmet İlker
Department of Cardiology, Dr. Siyami Ersek Thoracic and Cardiovascular Surgery, Training and Research Hospital, İstanbul, Turkey.
Turk Kardiyol Dern Ars. 2019 Jan;47(1):10-20. doi: 10.5543/tkda.2018.32657. Epub 2018 Oct 15.
The aim of the present study was to evaluate in-hospital and long-term outcomes of ST-segment elevation myocardial infarction (STEMI) survivors who experienced out-of-hospital cardiac arrest (OHCA) and underwent primary percutaneous coronary intervention (PCI) at a high-volume center within the STEMI network.
The records of 2681 consecutive STEMI patients who underwent primary PCI between January 2009 and December 2014 at a single center in the STEMI network were retrospectively analyzed. Patients with STEMI complicated by OHCA were compared with a reference group of STEMI patients who did not experience OHCA.
Compared with STEMI survivors without OHCA (n=2587, 96.5%), the frequency of anterior myocardial infarction, duration of hospitalization, rate of in-hospital major adverse cardiovascular and cerebrovascular events, and the incidence of ischemic cerebrovascular disease and major bleeding during in-hospital follow-up were significantly greater in those with OHCA (n=94, 3.5%). The distribution of age and gender was similar between the 2 groups. The primary PCI success rate was high and was similar in both groups. In-hospital mortality was significantly higher (18.1% vs. 1.5%; p<0.001) and survival at the 12th and 60th months was lower (74.5% vs. 96.5%; p<0.001 and 71.3% vs. 93.7%; p<0.001) in STEMI survivors with OHCA. OHCA was an independent predictor for in-hospital mortality (Odds ratio [OR]: 3.413; 95% confidence interval [CI]: 1.534-7.597; p=0.003) and all-cause mortality at 60 months (OR: 3.285; 95% CI: 2.020-5.340; p<0.001).
Mortality was high in patients with STEMI complicated by OHCA, even though PCI was performed with the same success rate seen in patients without OHCA.
本研究旨在评估在ST段抬高型心肌梗死(STEMI)网络中的一家大型中心,经历院外心脏骤停(OHCA)并接受直接经皮冠状动脉介入治疗(PCI)的STEMI幸存者的院内及长期预后。
回顾性分析2009年1月至2014年12月期间在STEMI网络中的一个中心连续接受直接PCI的2681例STEMI患者的记录。将并发OHCA的STEMI患者与未经历OHCA的STEMI患者参照组进行比较。
与未发生OHCA的STEMI幸存者(n = 2587,96.5%)相比,发生OHCA的患者(n = 94,3.5%)前壁心肌梗死的频率、住院时间、院内主要不良心血管和脑血管事件发生率以及院内随访期间缺血性脑血管疾病和大出血的发生率显著更高。两组间年龄和性别的分布相似。直接PCI成功率很高且两组相似。并发OHCA的STEMI幸存者院内死亡率显著更高(18.1% 对1.5%;p < 0.001),在第12个月和60个月时的生存率更低(74.5% 对96.5%;p < 0.001以及71.3% 对93.7%;p < 0.001)。OHCA是院内死亡率(比值比[OR]:3.413;95%置信区间[CI]:1.534 - 7.597;p = 0.003)和60个月时全因死亡率(OR:3.285;95% CI:2.020 - 5.340;p < 0.001)的独立预测因素。
并发OHCA的STEMI患者死亡率很高,尽管PCI成功率与未发生OHCA的患者相同。